课题基金 / 基金详情

Studies on Tissue Morphogenesis, Organogenesis and Repair by HGF

Studies on Tissue Morphogenesis, Organogenesis and Repair by HGF
HGF 的组织形态发生、器官发生和修复研究
批准号:
11308025
负责人:
NAKAMURA Toshikazu
金额:
$25.13万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

NAKAMURA Toshikazu的其他基金

相似基金

相关文献

中文摘要
翻译
HGF是我们实验室发现并克隆的一种促肝因子。我们积累的证据表明,HGF具有多性功能,如有丝分裂、运动发生、形态发生等。基于这些背景,我们假设HGF可能作为间质衍生因子在形态发生和组织修复中发挥重要作用。为了验证我们的假设,我们在最近3年集中研究了HGF的生理作用。通过急性和慢性疾病的动物模型,我们证明了HGF是一种必不可少的内在修复因子:在损伤模型中,内源性HGF在组织破坏发生后急剧增加。重要的是,抗hgf IgG强烈抑制实质细胞(包括肝细胞、肾小管细胞、肺细胞、肺泡细胞等)的再生反应;从而表明内源性HGF是体内组织再生的关键参与者。相反,补充外源性HGF导致组织再生加速,在实质损伤(包括肝硬化、肾纤维化、肺病和心脏病等)中表现得更为明显。在肿瘤恶性形成过程中,HGF参与肿瘤侵袭和血管生成。因此,我们制备了NK4/HGF作为HGF的拮抗剂,发现NK4可使肿瘤的恶性程度最小化,同时抑制肿瘤的转移、侵袭和血管生成。有趣的是,NK4对几种类型的血管生成表现出广泛的抗血管生成活性,不依赖于hgf介导的内皮生长。通过这些体内和体外研究,我们获得了证据,证明NK4可能通过抗侵入性和抗血管生成谱对肿瘤恶性肿瘤的最小化有用。最后,我们分析了LIMK激酶(LIMK)激活的调控系统:我们发现LIMK1在Rac和Pac级联下游的调控下激活,而LIMK2在Rho和ROCK流下激活。此外,我们发现LIMK2在体内精子发生中起着关键作用,使用LIMK2基因靶向小鼠。通过这些实验,我们得出结论,HGF(可能还有它的家族分子)在形态发生和组织修复中起着关键作用。少
英文摘要
HGF was found and cloned as a hepatotropic factor in our laboratory : We have accumulated evidence that HGF has pleotropic functions such as mitogenesis, motogenesis, morphogenesis and so on. Based on these backgrounds, we hypothesized that HGF plays an important role for morphogenesis and tissue repair, possibly as a mesenchyme-derived factor.To test our hypothesis, we focused during the recent 3 years, on physiological roles by HGF. Using animal models for acute and chronic diseases, we demonstrated that HGF is an essential intrinsic repair factor : In the injury models, endogenous HGF dramatically increased after onset of tissue destruction. Of importance, an anti-HGF IgG strongly suppressed regenerative responses by parenchymal cells (including liver hepatocytes, renal tubular cells lung; alveolar cells etc...); thereby suggesting that endogenous HGF is a key player for eliciting tissue regeneration in vivo. Conversely, supplement of exogenous HGF led to acceleration of tissue repa … More ir in parenchymal injuries (including liver cirrhosis, renal fibrosis, lung and heart diseases and so on).In tumor malignant formation, HGF is participated in tumor invasion and angiogenesis. Thus we prepared NK4/HGF as an antagonist for HGF and found that NK4 minimized tumor malignancy, accompanied with repressed tumor metastasis, invasion and angiogenesis. Of interest, NK4 shows broad anti-angiogenetic activities toward several types of angiogenesis, independent on HGF-mediated endothelial growth. Through these in vivo and in vitro studies, we obtained evidence that NK4 is useful for minimization, of tumor malignancy, possibly through anti-invasive and anti-angiogenetic profiles.Finally, we analyzed a regulation system for activation of LIM-kinase (LIMK) : We found that LIMK1 is activated under regulations under down-streams of Rac and Pac cascades while LIMK2 activation occurs under Rho and ROCK streams. Furthermore, we found that LIMK2 plays a critical role in spermatogenesis in vivo, using a gene-targeted mice for LIMK2.Throughout these experiments, we conclude that HGF (and possibly, its family molecules) are critically involved in morphogenesis and tissue repair. Less
期刊论文(118)
专著(0)
科研奖励(0)
会议论文
Mizuno, S., et al.: "Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy"Kidney Intern. 59. 1304-1314 (2001)
Mizuno, S. 等人:“肝细胞生长因子抑制梗阻性肾病小鼠模型中的间质纤维化”肾脏实习生。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuzuki, N., et al.: "HGF reduces the infarct volume after transient focal cerebral ischemia in rats"Neurol Res.. 23. 417-424 (2001)
Tsuzuki, N. 等人:“HGF 减少大鼠短暂局灶性脑缺血后的梗塞体积”Neurol Res.. 23. 417-424 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Shibuki, et al.: "Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemic-reperfusion injury"Invest.Ophthalmol.Vis.Sci.. 43. 528-536 (2002)
H.Shibuki等人:“视网膜缺血再灌注损伤中肝细胞生长因子的表达和神经保护作用”Invest.Ophasemol.Vis.Sci..43.528-536(2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taniyama, Y. et al.: "Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model : molecular mechanisms of delayed angiogenesis in diabetes"Circulation. 104. 2344-2350 (2001)
Taniyama,Y.等人:“在大鼠糖尿病后肢缺血模型中由人肝细胞生长因子基因诱导的治疗性血管生成:糖尿病中延迟血管生成的分子机制”循环。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 109 条
    DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
    • 批准号:
      24654112
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
    • 批准号:
      21390079
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2009
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
    • 批准号:
      20340095
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.49万
    • 财政年份:
      2008
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
    • 批准号:
      18390087
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.57万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    海外基金